CHE Jennifer, J.D.
- Vice President, Eagle IP Ltd
Jennifer is a US patent attorney with a deep, multi-faceted understanding of the biopharmaceutical industry. She has a strong track record of driving creative and unique IP strategies for various types of products, research collaborations and business development deals. Having worked as a scientist, patent attorney, and executive over her 20-year career, Jennifer has a deep appreciation and understanding for how to devise IP strategies that take into account both the technical as well as the long-range business needs of an organization.
Jennifer spent over ten years at Vertex Pharmaceuticals, a 40 billion USD S&P 500 pharmaceutical company, building up sophisticated global patent portfolios for the company’s UK and Canada research and development sites. Prior to joining Eagle IP, Jennifer was Vice President of IP and legal affairs at Axcella, a venture-back biotech startup focused on addressing metabolic dysregulation by leveraging amino acid biology.
Jennifer has a strong scientific foundation, from her chemistry degree at MIT to her six years working as a medicinal chemist at Takeda Oncology (formerly Millennium Pharmaceuticals). Jennifer has extensive experience in small molecules, large molecules, biotechnology, and nanotechnology-based therapeutics in a broad range of disease areas.
Jennifer advises clients on global patent strategy, IP portfolio management, patent drafting and filing strategy, IP ownership, and more. Her areas of expertise include chemistry, pharmaceuticals, formulations, biotechnology, medicine, drug-delivery systems, and nanotechnology-based therapeutics in a broad range of disease areas.
Her working languages are English and Mandarin Chinese.